Skelaxin (metaxalone) is not a narcotic. It is a muscle relaxant that works through mild sedation of the central nervous system, and it is not classified as a controlled substance by the DEA. You do not need a special prescription to obtain it, and it carries none of the legal restrictions associated with narcotics like oxycodone or hydrocodone.
How Skelaxin Actually Works
Narcotics (opioids) relieve pain by binding to specific opioid receptors in the brain and spinal cord. Skelaxin does something entirely different. Its exact mechanism hasn’t been fully established, but the FDA notes it likely works through general central nervous system depression, essentially a mild calming effect on the brain that reduces the perception of muscle tension. It has no direct action on muscle fibers, nerve endings, or the connections between nerves and muscles. It doesn’t relax your muscles the way you might assume from the name “muscle relaxant.” Instead, it dials down the brain’s response to the discomfort.
Skelaxin is approved to treat pain and discomfort from acute musculoskeletal conditions, things like back strains, neck injuries, and muscle spasms. It’s meant for short-term use alongside rest and physical therapy, not as a standalone long-term treatment.
Why People Confuse It With a Narcotic
The confusion makes sense. Skelaxin can cause drowsiness, dizziness, and a general “foggy” feeling, side effects that overlap with what people associate with narcotics. Some muscle relaxants, like carisoprodol (Soma), are actually classified as Schedule IV controlled substances because of their higher abuse potential. Skelaxin doesn’t fall into that category. It sits in a different pharmacological class (oxazolidinone derivatives) and has not been placed on any DEA controlled substance schedule.
A 2024 systematic review published in JAMA Network Open looked at long-term use of skeletal muscle relaxants for chronic pain and found no studies had even measured misuse rates for these drugs as a class. That doesn’t mean misuse is impossible, but it reflects how low the concern is compared to opioids or benzodiazepines.
Common Side Effects
The most frequently reported side effects, with an incidence above 5% in clinical trials, are nausea and vomiting. Beyond those, the FDA label lists several other reactions:
- Nervous system: drowsiness, dizziness, headache, nervousness or irritability
- Digestive: nausea, vomiting, general stomach upset
Drowsiness is the side effect most people notice first. It tends to be milder than what you’d experience with some other muscle relaxants, which is one reason Skelaxin is sometimes preferred for people who need to stay relatively functional during the day. That said, it can still impair your ability to drive or operate machinery, especially when you first start taking it or if you combine it with alcohol.
Serotonin Syndrome Risk
One safety concern that doesn’t get enough attention is the risk of serotonin syndrome. This is a potentially serious reaction that can happen when Skelaxin is combined with medications that increase serotonin levels in the brain. The list of drugs that can trigger this interaction is long: common antidepressants (SSRIs and SNRIs), certain migraine medications (triptans), some pain medications including tramadol, and MAO inhibitors.
Serotonin syndrome can also occur with metaxalone alone at higher-than-recommended doses. Symptoms typically appear within hours to a few days and can include agitation, confusion, rapid heart rate, unstable blood pressure, elevated body temperature, muscle rigidity, and nausea. If you take an antidepressant or any other medication that affects serotonin, this interaction is worth flagging with your pharmacist.
How It Compares to Controlled Muscle Relaxants
Not all muscle relaxants share the same risk profile. Carisoprodol (Soma) is a Schedule IV controlled substance because it converts into meprobamate, an older sedative with real addiction potential, once your body metabolizes it. Cyclobenzaprine (Flexeril) is not a controlled substance either, but it’s structurally similar to tricyclic antidepressants and tends to cause more sedation than Skelaxin. Tizanidine (Zanaflex) works differently altogether, acting on receptors in the spinal cord, and can cause significant drops in blood pressure.
Skelaxin occupies a middle ground: effective enough for acute muscle pain, mild enough in its side effect profile that it’s generally considered one of the better-tolerated options. Its lack of controlled substance status reflects both its pharmacology and the absence of documented patterns of abuse or physical dependence in clinical research.
If you’re filling a prescription for Skelaxin, you won’t encounter the additional hurdles that come with controlled substances. There are no limits on refills tied to scheduling, no requirement for a new prescription each time, and no monitoring through prescription drug monitoring programs the way there would be with a narcotic.